Albert D Mason Inc Pfizer Inc Transaction History

Albert D Mason Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$33.49 - $37.77 $349,334 - $393,978	-10,431 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $37,750 - $44,290	1,189 Added 12.87%	10,431 $383,000
Q1 2020 Apr 15, 2020	BUY	$27.03 - $38.62 $10,541 - $15,061	390 Added 4.41%	9,242 $302,000
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $291,407 - $330,710	8,852 New	8,852 $347,000
Q3 2019 Oct 23, 2019	SELL	$32.49 - $42.13 $172,911 - $224,215	-5,322 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $4,992 - $5,605	-135 Reduced 2.47%	5,322 $231,000
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $17,400 - $19,116	-464 Reduced 7.84%	5,457 $232,000
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $35,848 - $43,482	-1,040 Reduced 14.94%	5,921 $261,000
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $47,326 - $50,454	-1,435 Reduced 17.09%	6,961 $253,000
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $267,916 - $310,819	8,396 New	8,396 $298,000

3,231

3.72B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Albert D Mason Inc, based on Form 13F filings with the SEC.

Stay updated on Albert D Mason Inc with notifications on news.